Compound Evidence File
#EC-2026-0454
BAC Water
Filed under Peptides. The bureau holds 148 laboratory returns for this compound from 50 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
50 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Jan 2026 | 25 May 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Mar 2026 | 10 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Feb 2026 | 9 Aug 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 22 Mar 2026 | 12 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 21 Dec 2025 | 5 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 6 Jan 2026 | 25 Mar 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 10.0 | 10.0 | 14 Dec 2025 | 27 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 9.9 | 10.0 | 5 May 2026 | 9 Aug 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 4 Jun 2026 | 13 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Jan 2026 | 11 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Mar 2026 | 25 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Dec 2025 | 8 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 19 Jan 2026 | 3 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 10.0 | 13 Nov 2025 | 3 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Mar 2026 | 13 Apr 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 9.9 | 9.9 | 10.0 | 1 Feb 2026 | 8 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 9.9 | 9.9 | 10.0 | 4 Mar 2026 | 21 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 9.9 | 18 Jan 2026 | 25 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Feb 2026 | 10 May 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 9.9 | 23 Apr 2026 | 14 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 5 May 2026 | 16 Aug 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 3 | 9.1 | 8.2 | 9.8 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.8 | 7.5 | 10.0 | 24 May 2026 | 24 May 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.8 | 8.8 | 8.8 | 8 Jul 2025 | 8 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.7 | 8.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.6 | 7.7 | 9.8 | 21 May 2026 | 21 May 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 8.6 | 8.6 | 8.6 | 3 Jun 2025 | 3 Jun 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 7 | 8.3 | 6.3 | 9.9 | 21 May 2025 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.0 | 7.4 | 8.6 | 21 May 2026 | 21 May 2026 |
| PeptiSlimCASE #VI-2026-0557 | X | 3 | 7.8 | 5.3 | 9.2 | 25 Apr 2025 | 25 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 4 | 7.3 | 5.9 | 9.3 | 3 Jul 2025 | 25 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 3 | 6.8 | 6.1 | 7.6 | 14 Jan 2025 | 17 May 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 6.8 | 6.8 | 6.8 | 24 Apr 2025 | 24 Apr 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 3 | 6.5 | 6.3 | 7.0 | 14 Jan 2025 | 20 May 2026 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 6.4 | 6.4 | 6.4 | 2 Jul 2025 | 2 Jul 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 1 | 6.0 | 6.0 | 6.0 | 16 Mar 2025 | 16 Mar 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 2 | 5.5 | 5.0 | 5.9 | 9 Jun 2025 | 24 May 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 5.4 | 5.4 | 5.4 | 14 Jan 2025 | 14 Jan 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 1 | 5.2 | 5.2 | 5.2 | 3 Jun 2025 | 3 Jun 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 5.0 | 5.0 | 5.0 | 13 Jun 2025 | 13 Jun 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 3 | 4.7 | 1.6 | 8.2 | 27 Feb 2025 | 19 Jan 2026 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 4.6 | 4.6 | 4.6 | 8 Jul 2025 | 8 Jul 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 4.5 | 4.5 | 4.5 | 3 Jul 2025 | 3 Jul 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 4.3 | 4.3 | 4.3 | 16 Mar 2025 | 16 Mar 2025 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 1 | 3.9 | 3.9 | 3.9 | 21 May 2025 | 21 May 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 0.4 | 0.4 | 0.4 | 14 Jan 2025 | 14 Jan 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Feb 2025 | 13 Feb 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.0 | 0.0 | 0.0 | 17 Dec 2024 | 17 Dec 2024 |
Open any subject to view the batch-level evidence for BAC Water alone.